These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798 [TBL] [Abstract][Full Text] [Related]
15. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815 [TBL] [Abstract][Full Text] [Related]
16. CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure. Wan Z; You S; Rong Y; Zhu B; Zhang A; Zang H; Xiao L; Xie G; Xin S Dig Dis Sci; 2013 Feb; 58(2):448-57. PubMed ID: 23095991 [TBL] [Abstract][Full Text] [Related]
17. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941 [TBL] [Abstract][Full Text] [Related]
18. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells. Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760 [TBL] [Abstract][Full Text] [Related]
20. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors. Pilarski LM; Belch AR Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]